AIMP1 and neoplasm: EMAP II exerts tumor-suppressive functions in pancreatic ductal adenocarcinoma cells and anti-tumor activity in human prostate adenocarcinoma xenografts (Reznikov et al., 2007; Schwarz et al., 2010).